Literature DB >> 8559202

A reversible posterior leukoencephalopathy syndrome.

J Hinchey1, C Chaves, B Appignani, J Breen, L Pao, A Wang, M S Pessin, C Lamy, J L Mas, L R Caplan.   

Abstract

BACKGROUND AND METHODS: In some patients who are hospitalized for acute illness, we have noted a reversible syndrome of headache, altered mental functioning, seizures, and loss of vision associated with findings indicating predominantly posterior leukoencephalopathy on imaging studies. To elucidate this syndrome, we searched the log books listing computed tomographic (CT) and magnetic resonance imaging (MRI) studies performed at the New England Medical Center in Boston and Hôpital Sainte Anne in Paris; we found 15 such patients who were evaluated from 1988 through 1994.
RESULTS: Of the 15 patients, 7 were receiving immunosuppressive therapy after transplantation or as treatment for aplastic anemia, 1 was receiving interferon for melanoma, 3 had eclampsia, and 4 had acute hypertensive encephalopathy associated with renal disease (2 with lupus nephritis, 1 with acute glomerulonephritis, and 1 with acetaminophen-induced hepatorenal failure). Altogether, 12 patients had abrupt increases in blood pressure, and 8 had some impairment of renal function. The clinical findings included headaches, vomiting, confusion, seizures, cortical blindness and other visual abnormalities, and motor signs. CT and MRI studies showed extensive bilateral white-matter abnormalities suggestive of edema in the posterior regions of the cerebral hemispheres, but the changes often involved other cerebral areas, the brain stem, or the cerebellum. The patients were treated with antihypertensive medications, and immunosuppressive therapy was withdrawn or the dose was reduced. In all 15 patients, the neurologic deficits resolved within two weeks.
CONCLUSIONS: Reversible, predominantly posterior leukoencephalopathy may develop in patients who have renal insufficiency or hypertension or who are immunosuppressed. The findings on neuroimaging are characteristic of subcortical edema without infarction.

Entities:  

Mesh:

Year:  1996        PMID: 8559202     DOI: 10.1056/NEJM199602223340803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  728 in total

1.  Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.

Authors:  G Pratt; B Kennedy; G Smith
Journal:  BMJ       Date:  1999-07-03

2.  Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?

Authors:  S O Casey; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

Review 3.  Neuropsychiatric complications of liver transplantation.

Authors:  A Stracciari; M Guarino
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

4.  Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

Authors:  J M Provenzale; J R Petrella; L C Cruz; J C Wong; S Engelter; D P Barboriak
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

5.  Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome.

Authors:  Florian S Eichler; Paul Wang; Robert J Wityk; Norman J Beauchamp; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

6.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

7.  Cortical blindness and posterior reversible encephalopathy syndrome in an older patient.

Authors:  Sabrina Ait; Thomas Gilbert; Francois Cotton; Marc Bonnefoy
Journal:  BMJ Case Rep       Date:  2012-05-26

8.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

9.  Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.

Authors:  Hilde M H Braakman; Jan Lodder; Alida A Postma; Lambert F R Span; Werner H Mess
Journal:  BMC Neurol       Date:  2010-05-11       Impact factor: 2.474

Review 10.  Headache in patients with cancer.

Authors:  Samuel A Goldlust; Jerome J Graber; Dana F Bossert; Edward K Avila
Journal:  Curr Pain Headache Rep       Date:  2010-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.